Mutluay Arslan

Dr. Mutluay Arslan

Assoc prof
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
SCSara Capiau
Sara Capiau
JSJoél EG Smet
Joél EG Smet
Boel De PaepeBoel De Paepe
Boel De Paepe
YYYILMAZ YILDIZ
YILMAZ YILDIZ
MAMutluay Arslan
Mutluay Arslan
AVArnaud Vanlander
Arnaud Vanlander
Human mitochondrial disease exhibits large variation of clinical phenotypes, even in patients with the same causative gene defect. We illustrate this heterogeneity by confronting clinical and biochemical data of two patients with the uncommon pathogenic homoplasmic NC_012920.1(MT-ATP6):m.9035T>C variant in MT-ATP6. Patient 1 presented as a toddler with severe motor and speech delay and spastic ataxia without extra-neurologic involvement. Patient 2 presented in adolescence with ataxia and ophthalmoplegia without cognitive or motor impairment. Respiratory chain complex activities were normal in cultured skin fibroblasts from both patients when calculated as ratios over citrate synthase activity. Native gels found presence of subcomplexes of complex V in fibroblast and/or skeletal muscle. Bioenergetic measurements in fibroblasts from both patients detected reduced spare respiratory capacities and altered extracellular acidification rates, revealing a switch from mitochondrial respiration to glycolysis to uphold ATP production. Thus, in contrast to the differing disease presentation, biochemical evidence of mitochondrial deficiency turned out quite similar. We conclude that biochemical analysis remains a valuable tool to confirm the genetic diagnosis of mitochondrial disease, especially in patients with new gene variants or atypical clinical presentation.


1 December 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
MMMina Mısırlıgil
Mina Mısırlıgil
YYYILMAZ YILDIZ
YILMAZ YILDIZ
OAOnur Akın
Onur Akın
SGSevinç Odabaşı Güneş
Sevinç Odabaşı Güneş
MAMutluay Arslan
Mutluay Arslan
BÜBülent Ünay
Bülent Ünay
Kabuki syndrome (KS) is a disease characterized by distinctive facial features, skeletal anomalies and delay in neuromotor development. KS 1 is an autosomal dominant condition caused by mutations in the KMT2D gene, whereas KS 2 is an X-linked disorder caused by mutations in the KDM6A gene. In the majority of KS patients who present with hypoglycemia, KDM6A is the defective gene. A 9-month old girl was admitted to our emergency department due to a seizure. On physical examination, hypotonia, mild facial dysmorphism, brachydactyly of the 5th finger, prominent finger pads and pansystolic murmur were detected. A fasting glucose tolerance test was performed the next day due to her history of hypoglycemia, but she had convulsions at the fifth hour of the test. Her serum glucose was 24 mg/dL, insulin 1.94 mIU/L, C-peptide 0.94 ng/mL, growth hormone 11 ng/mL, anti-insulin antibody 4.2 IU/mL, cortisol 19.8 mu g/dL, and adrenocorticotropic hormone 9.3 pg/mL. A diagnosis of hyperinsulinemic hypoglycemia was considered. Given the abnormalities, genetic analysis for congenital hyperinsulinism, including the genes causing KS was performed. A heterozygous frameshift mutation (c.2579del, p.Leu860Argfs*70) was detected in the KMT2D gene. Epilepsy and other neurological symptoms may be seen in KS patients and in some of these the neurological symptoms are the result of hypoglycemia. In such cases, the detection and prevention of hypoglycemia can help prevent the progression of neurological symptoms. We suggest considering the diagnosis of KS for patients with hypoglycemia and dysmorphic features, even if the patient does not manifest all features of KS.

1 September 2012 in Epilepsy & Behavior
Verified
Journal Article
Closed access
MAMutluay Arslan
Mutluay Arslan
UYUluç Yiş
Uluç Yiş
SVSebahattin Vurucu
Sebahattin Vurucu
SISemra İnce
Semra İnce
BÜBülent Ünay
Bülent Ünay
RARıdvan Akın
Rıdvan Akın

1 October 2012 in Brain and Development
Verified
Journal Article
Closed access
MAMutluay Arslan
Mutluay Arslan
UYUluç Yiş
Uluç Yiş
SVSebahattin Vurucu
Sebahattin Vurucu
YTYusuf Tunca
Yusuf Tunca
BÜBülent Ünay
Bülent Ünay
RARıdvan Akin
Rıdvan Akin

30 April 2022 in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
HEHanifi Erol
Hanifi Erol
MSMeral Sertel
Meral Sertel
AAAyşegül ALPCAN
Ayşegül ALPCAN
MAMutluay Arslan
Mutluay Arslan
Objective: This study aimed to evaluate physical activity and physical fitness in adolescents with cerebral palsy.Material and Methods: Forty individuals (20 cerebral palsy and 20 asymptomatic adolescents) were included in the study. Physical activity levels were measured by Physical Activity Questionnaire for Adolescents; balance, agility, flexibility and arm movement speed, which are physical fitness parameters, were evaluated with Eurofit test battery; lower extremity muscle strength was evaluated with Muscle Force Evaluation Form; functional independence in the quality of life the individuals was evaluated with Functional Independence Measurement scales and cardiopulmonary endurance was assessed by 6-minute walking test.Results: In statistical analysis, there was no significant difference between two groups for the assessment of agility, 6-minute walk test, flexibility, arm movement speed, balance. There was a significant difference in physical activity and functional independence in favor of asymptomatic group.Conclusion: As a result of our study, it was determined that the levels of physical activity and physical fitness of the adolescents with cerebral palsy were lower. We believe that it is important to direct these individuals to sports and recreational activities, to increase their physical activity and fitness levels, and to reduce difference with their asymptomatic peers.